SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-11-078001
Filing Date
2011-03-25
Accepted
2011-03-25 15:13:56
Documents
12
Effectiveness Date
2011-03-25

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ddefa14a.htm DEFA14A 56203
2 GRAPHIC g148257g15q96.jpg GRAPHIC 62355
3 GRAPHIC g148257g25i75.jpg GRAPHIC 2456
4 GRAPHIC g148257g38c63.jpg GRAPHIC 19786
5 GRAPHIC g148257g43a16.jpg GRAPHIC 19466
6 GRAPHIC g148257g43e89.jpg GRAPHIC 22030
7 GRAPHIC g148257g50e67.jpg GRAPHIC 2666
8 GRAPHIC g148257g64v68.jpg GRAPHIC 1175
9 GRAPHIC g148257g68z02.jpg GRAPHIC 15965
10 GRAPHIC g148257g77g12.jpg GRAPHIC 24873
11 GRAPHIC g148257g78z33.jpg GRAPHIC 2455
12 GRAPHIC g148257g84m58.jpg GRAPHIC 2455
  Complete submission text file 0001193125-11-078001.txt   300906
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-31577 | Film No.: 11712345
SIC: 2834 Pharmaceutical Preparations